As a rising star in global medical device sector, Medimaging Integrated Solution Inc. (MiiS) is a trusted partner of Hospitals, Medical Schools, and Health Organizations, providing worldwide practitioners with first-class digital and portable diagnostic solutions.
Since its establishment, MiiS has been involved in the design and manufacturing of digital hand-held diagnostic scopes that meet the highest quality standard in the world. In addition, the Company produces auxiliary tools to enhance effectiveness and efficiency of healthcare practice.
2010
Originated from the incubation center at the National Chiao Tung University (NCTU), Taiwan, MiiS started its business primarily based on the foundation of innovation.
2011
Established a medical equipment assembly factory "RD2".
Obtained ISO13485 quality system certificate.
2012
Factory "RD2" obtained TFDA GMP registration letter.
Obtained the first TFDA Class II certificate of eye fundus camera.
Obtained the first 510K letter of eye fundus camera, and obtained 510k letter of slip lamp and tonometer in the coming years.
Obtained the first CE MDD Class II certificate of eye fundus camera.
2013
Passed the Japan GMP audit.
Passed the KFDA GMP audit.
2014
Passed the first FDA QSR audit for eye fundus camera.
Obtained the first CFDA (NMPA) Class II certificate of eye fundus camera.
2018
Passed the first FDA QSR audit for digital hand-held slit lamp.
Established a medical equipment assembly factory "IE4".
2019
Factory "IE4" obtained TFDA GMP registration letter.
Selected and participated in Bayer Taiwan G4A X H.Spectrum Innovation Program
2020
Established Factory "IE4-2" for the manufacturing of micro camera module.
2021
Emerging Stock Board Registration
Got the opinion letter for science and technology business issued by MOEA-IDB
2022
IPO at TSE (Taiwan Stock Exchange)
Obtained the TFDA Class II Certificate (Nasopharyngoscope)
Obtained the EU CE Certificate (Digital Otoscope)
Obtained the FDA 510K Certificate (Nasopharyngoscope)
2023
Obtained the EU CE Certificate (Smart Wound Carer)
Obtained the Thai FDA Certificate (Optical Coherence Tomography)
Obtained the Japan PMDA Class II Certificate (Nasopharyngoscope)
The products of the Company, namely Horus Scope, address unique problems related to healthcare and emerging technology to have a positive impact on the medical world. The solutions provided by the Company have to meet an absolute Quality standard, including but not limited to ISO 13485, 9001, FDA, and CE mark. Achieving and maintaining leadership requires that all MiiS operations work together to consistently bring value to worldwide customers with the following capabilities:
Technology
Processes
Customer and Market
Understanding
Industry Skills
and Experience
Looking forward, MiiS will strive to extend these strengths and share the fruits of its ongoing investments to deliver long term profitable growth. The goal is to ensure that Horus Scope stays at the forefront of technological innovation and exceeds customer expectations while rewarding employees for their dedication and high performance.
Taiwan Excellence Award
2017 Fundus Camera (DEC 200 ) Gold Award
Taiwan BIO Awards
2023 Innovation of the Year
INPEX (USA)
2017 Invention and New Product Exposition Gold Award Total solution of digital medical scope products
Taipei Biotech Awards
2017 Innovation Gold Award Horus Digital Fundus Camera DEC 200
iF Design Award
iF Design Award 2021 Device with AI computing for diabetic retinopathy (DIB 100+DEC 200+DSC 300)MiiS has acquired the following certifications:
